Quad Leaders Praise India's COVID-19 Vaccine Donation
Date
5/25/2022 7:53:01 PM
(MENAFN- Trend News Agency)
The leaders of the Quad countries during their Summit in Tokyo
on Tuesday welcomed India's gift of 525,000 doses of Made in India
vaccines to Thailand and Cambodia in April this year under the Quad
Vaccine Partnership, Trend reports citing India
Blooms .
'We celebrate the donation by the Quad to Cambodia and Thailand
of WHO approved the Made in India vaccines, together with Quad
members' other vaccine related support, as an example of tangible
achievement of our collaboration,' a joint statement issued after
the summit read.
'We will continue to address both the COVID-19 response and
preparedness against future health threats,' the statement
added.
Reviewing Quad's ongoing efforts to combat the Covid-19
pandemic, the leaders welcomed the enhanced manufacturing capacity
of Biological-E facility in India and called for the expeditious
grant of EUL approval by the WHO so that delivery of vaccines can
commence.
The joint statement said that the Quad countries have led and
will continue to lead global efforts for Covid-19 response, with a
view to building better health security and strengthening health
systems.
'We commit to adapt our collective approaches to get ahead of
the virus with a focus on preparing for new variants, and getting
vaccines, tests, treatments, and other medical products to those at
highest risk,' the statement added.
The Quad countries said that they were proud to have delivered
over 670 million doses, including at least 265 million, to the
Indo-Pacific.
'We will accelerate getting shots in arms through last mile
support of which over 2 billion USD has been provided in more than
115 countries globally by our four countries, and will also address
vaccine hesitancy through a Quad-convened event this week at the
World Health Assembly,' the statement said.
Tags:
MENAFN25052022000187011040ID1104275249
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.